The company will scale its weight loss offerings ahead of generic GLP-1s coming to the Canadian market in 2026.
Matt Faustman, Honey Health's founder and CEO, said that in 2026 organizations will be looking for an operational platform ...
Oncology-focused biotech company Guardant Health is partnering with AI drug development company Zephyr AI to combine AI and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback